Genmab A/S - American Depositary Shares – Jahresabschlüsse (NASDAQ:GMAB)

Genmab A/S - American Depositary Shares

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

GMAB

Financials

Genmab A/S - American Depositary Shares

Nachrichten

Genmab: Multiple Binaries Could Alter The Thesis (NASDAQ:GMAB)

JNJ: Success In Multiple Myeloma Underpins $25B In Growth By 2030 (NYSE:JNJ)

Wolfe Research stuft Genmab-Aktie mit "Outperform" ein

Genmab ernennt neue Führungsspitze und vergibt aktienbasierte Vergütung

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.00%

Harbor Health Care ETF Q4 2025 Portfolio Review

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.20%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.23%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 2.42%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.18%

Wells Fargo startet Coverage für Genmab mit ’Overweight’-Rating

Wells Fargo initiates Genmab stock coverage with overweight rating